Kurs & Likviditet
Kalender
2024-10-29 | Kvartalsrapport 2024-Q3 |
2024-10-15 | Halvårsutdelning ORNBV 0.81 |
2024-10-15 | Halvårsutdelning ORNAV 0.81 |
2024-08-08 | Kvartalsrapport 2024-Q2 |
2024-04-25 | Kvartalsrapport 2024-Q1 |
2024-03-21 | Halvårsutdelning ORNAV 0.81 |
2024-03-21 | Halvårsutdelning ORNBV 0.81 |
2024-03-20 | Årsstämma 2024 |
2024-02-13 | Bokslutskommuniké 2023 |
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-07-17 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-03-23 | Ordinarie utdelning ORNAV 1.60 EUR |
2023-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
2023-03-22 | Årsstämma 2023 |
2023-02-09 | Bokslutskommuniké 2022 |
2022-10-20 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-03-24 | Ordinarie utdelning ORNAV 1.50 EUR |
2022-03-24 | Ordinarie utdelning ORNBV 1.50 EUR |
2022-03-23 | Årsstämma 2022 |
2022-02-10 | Bokslutskommuniké 2021 |
2021-10-20 | Kvartalsrapport 2021-Q3 |
2021-07-19 | Kvartalsrapport 2021-Q2 |
2021-04-27 | Kvartalsrapport 2021-Q1 |
2021-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
2021-03-26 | Ordinarie utdelning ORNAV 1.50 EUR |
2021-03-25 | Årsstämma 2021 |
2021-02-09 | Bokslutskommuniké 2020 |
2020-10-21 | Kvartalsrapport 2020-Q3 |
2020-07-17 | Kvartalsrapport 2020-Q2 |
2020-05-07 | Ordinarie utdelning ORNBV 1.50 EUR |
2020-05-07 | Ordinarie utdelning ORNAV 1.50 EUR |
2020-05-06 | Årsstämma 2020 |
2020-04-28 | Kvartalsrapport 2020-Q1 |
2020-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-23 | Kvartalsrapport 2019-Q3 |
2019-07-17 | Kvartalsrapport 2019-Q2 |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-03-27 | Ordinarie utdelning ORNAV 1.50 EUR |
2019-03-27 | Ordinarie utdelning ORNBV 1.50 EUR |
2019-03-26 | Årsstämma 2019 |
2019-02-06 | Bokslutskommuniké 2018 |
2018-10-24 | Kvartalsrapport 2018-Q3 |
2018-07-18 | Kvartalsrapport 2018-Q2 |
2018-04-24 | Kvartalsrapport 2018-Q1 |
2018-03-21 | Ordinarie utdelning ORNBV 1.45 EUR |
2018-03-21 | Ordinarie utdelning ORNAV 1.45 EUR |
2018-03-20 | Årsstämma 2018 |
2018-02-07 | Bokslutskommuniké 2017 |
2017-10-26 | Kvartalsrapport 2017-Q3 |
2017-07-19 | Kvartalsrapport 2017-Q2 |
2017-05-18 | Kapitalmarknadsdag 2017 |
2017-04-26 | Kvartalsrapport 2017-Q1 |
2017-03-23 | Bonusutdelning ORNBV 0.2 |
2017-03-23 | Ordinarie utdelning ORNAV 1.35 EUR |
2017-03-23 | Bonusutdelning ORNAV 0.2 |
2017-03-23 | Ordinarie utdelning ORNBV 1.35 EUR |
2017-03-22 | Årsstämma 2017 |
2017-02-08 | Bokslutskommuniké 2016 |
2016-10-25 | Kvartalsrapport 2016-Q3 |
2016-07-19 | Kvartalsrapport 2016-Q2 |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-03-23 | Ordinarie utdelning ORNAV 1.30 EUR |
2016-03-23 | Ordinarie utdelning ORNBV 1.30 EUR |
2016-03-22 | Årsstämma 2016 |
2016-02-02 | Bokslutskommuniké 2015 |
2015-10-27 | Kvartalsrapport 2015-Q3 |
2015-07-28 | Kvartalsrapport 2015-Q2 |
2015-05-26 | Kapitalmarknadsdag 2015 |
2015-04-29 | Kvartalsrapport 2015-Q1 |
2015-03-25 | Ordinarie utdelning ORNBV 1.30 EUR |
2015-03-25 | Ordinarie utdelning ORNAV 1.30 EUR |
2015-03-24 | Årsstämma 2015 |
2015-02-04 | Bokslutskommuniké 2014 |
2014-10-21 | Kvartalsrapport 2014-Q3 |
2014-07-29 | Kvartalsrapport 2014-Q2 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-03-26 | Ordinarie utdelning ORNBV 1.25 EUR |
2014-03-26 | Ordinarie utdelning ORNAV 1.25 EUR |
2014-03-25 | Årsstämma 2014 |
2014-02-04 | Bokslutskommuniké 2013 |
2013-10-22 | Kvartalsrapport 2013-Q3 |
2013-07-30 | Kvartalsrapport 2013-Q2 |
2013-04-23 | Kvartalsrapport 2013-Q1 |
2013-03-20 | Ordinarie utdelning ORNAV 1.30 EUR |
2013-03-20 | Ordinarie utdelning ORNBV 1.30 EUR |
2013-03-19 | Årsstämma 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-10-23 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Kapitalmarknadsdag 2012 |
2012-04-24 | Kvartalsrapport 2012-Q1 |
2012-03-21 | Ordinarie utdelning ORNBV 1.30 EUR |
2012-03-21 | Ordinarie utdelning ORNAV 1.30 EUR |
2012-03-21 | Bonusutdelning ORNAV 0.12 |
2012-03-21 | Bonusutdelning ORNBV 0.12 |
2012-03-20 | Årsstämma 2012 |
2012-02-07 | Bokslutskommuniké 2011 |
2011-10-25 | Kvartalsrapport 2011-Q3 |
2011-08-02 | Kvartalsrapport 2011-Q2 |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-04-01 | Bonusutdelning ORNAV 0.06 |
2011-04-01 | Ordinarie utdelning ORNAV 1.20 EUR |
2011-04-01 | Ordinarie utdelning ORNBV 1.20 EUR |
2011-04-01 | Bonusutdelning ORNBV 0.06 |
2011-03-31 | Årsstämma 2011 |
2011-02-09 | Bokslutskommuniké 2010 |
2010-10-26 | Kvartalsrapport 2010-Q3 |
2010-08-10 | Kvartalsrapport 2010-Q2 |
2010-04-27 | Kvartalsrapport 2010-Q1 |
2010-03-25 | Bonusutdelning ORNBV 0.1 |
2010-03-25 | Ordinarie utdelning ORNBV 1.00 EUR |
2010-03-25 | Ordinarie utdelning ORNAV 1.00 EUR |
2010-03-25 | Bonusutdelning ORNAV 0.1 |
2009-03-24 | Ordinarie utdelning ORNBV 0.95 EUR |
2009-03-24 | Ordinarie utdelning ORNAV 0.95 EUR |
2008-03-26 | Ordinarie utdelning ORNBV 1.00 EUR |
2007-04-03 | Ordinarie utdelning ORNAV 1.00 EUR |
2007-04-03 | Ordinarie utdelning ORNBV 1.00 EUR |
2006-03-22 | Ordinarie utdelning ORNBV 0.85 EUR |
2005-03-22 | Ordinarie utdelning ORNAV 0.55 EUR |
2005-03-22 | Ordinarie utdelning ORNBV 0.55 EUR |
2004-09-15 | Bonusutdelning ORNBV 2.14 |
2004-09-15 | Bonusutdelning ORNAV 2.14 |
2004-03-23 | Ordinarie utdelning ORNAV 1.60 EUR |
2004-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
2003-12-12 | Bonusutdelning ORNBV 1.5 |
2003-12-12 | Bonusutdelning ORNAV 1.5 |
2003-03-23 | Ordinarie utdelning ORNAV 0.93 EUR |
2003-03-23 | Ordinarie utdelning ORNBV 0.93 EUR |
2002-04-16 | Ordinarie utdelning ORNAV 1.10 EUR |
2002-04-16 | Ordinarie utdelning ORNBV 1.10 EUR |
2001-03-30 | Ordinarie utdelning ORNAV 1.20 EUR |
2001-03-30 | Ordinarie utdelning ORNBV 1.20 EUR |
2000-03-31 | Ordinarie utdelning ORNBV 1.18 EUR |
2000-03-31 | Ordinarie utdelning ORNAV 1.18 EUR |
1999-07-28 | Bonusutdelning ORNBV 13.46 |
1999-07-28 | Bonusutdelning ORNAV 13.46 |
1999-04-09 | Ordinarie utdelning ORNAV 6.50 EUR |
1999-04-09 | Ordinarie utdelning ORNBV 6.50 EUR |
1998-04-21 | Ordinarie utdelning ORNBV 7.50 EUR |
1998-04-21 | Ordinarie utdelning ORNAV 7.50 EUR |
1997-04-22 | Ordinarie utdelning ORNBV 5.00 EUR |
1997-04-22 | Ordinarie utdelning ORNAV 5.00 EUR |
1996-04-23 | Ordinarie utdelning ORNAV 4.00 EUR |
1996-04-23 | Ordinarie utdelning ORNBV 4.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Large Cap Helsinki |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
ORION CORPORATION STOCK EXCHANGE RELEASE 25 MARCH 2021 at 5.55 p.m. EET
Orion Corporation: Organising meeting of the Board of Directors
In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Timo Maasilta as Vice Chairman.
The compositions of the Board committees were decided to be as follows:
Personnel and Remuneration Committee:
Mikael Silvennoinen, Chairman
Veli-Matti Mattila
Hilpi Rautelin
Audit Committee:
Ari Lehtoranta, Chairman
Kari Jussi Aho
Pia Kalsta
Eija Ronkainen
R&D Committee:
Hilpi Rautelin, Chairman
Kari Jussi Aho
Pia Kalsta
Ari Lehtoranta
Timo Maasilta
Veli-Matti Mattila
Eija Ronkainen
Mikael Silvennoinen
The name of the Remuneration Committee has been changed to the Personnel and Remuneration Committee.
The Company also has a Nomination Committee, the election of which was announced in a Stock Exchange Release on 21 October 2020.
All members of the Board of Directors have been assessed to be independent of the company and its significant shareholders.
Orion Corporation
Timo Lappalainen President and CEO | Olli Huotari SVP, Corporate Functions |
Contact person:
Olli Huotari, Senior Vice President, Corporate Functions
Phone +358 50 966 3054
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.